Dual upregulation of miRNA-143 and miRNA-506 in non-small cell lung cancer inhibits proliferation, motility, migration, and tumor growth
Lung cancer (LC) is the leading cause of cancer-related deaths worldwide and is primarily treated with chemotherapy or radiotherapy. The role of microRNAs (miRs) is increasingly studied in cancer therapeutics, as miRs can regulate multiple cancer-related pathways simultaneously. While numerous miRs...
Saved in:
| Main Authors: | Archana Shrestha, Md Anamul Haque, Prajesh Shrestha, Margarita Lamprou, Seetharama D. Jois, Constantinos M. Mikelis, George Mattheolabakis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Drug Discovery |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fddsv.2025.1584801/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel miRNA biomarkers for alveolar echinococcosis: sequencing and clinical validation
by: Jideng Ma, et al. -
Expressions and clinical significance of miR-9 and miR-214 in diabetic nephropathy
by: Bai Xiao-gang, et al.
Published: (2021-01-01) -
鼻咽癌差异表达miRNAs筛选研究
by: 李晓霞, et al.
Published: (2007-01-01) -
The potential of miRNA-based approaches in glioblastoma: An update in current advances and future perspectives
by: Edgar G. Ordóñez-Rubiano, MD, PhD (c), et al.
Published: (2024-01-01) -
Recent progress in microRNA-based delivery systems for the treatment of human disease
by: Yong Fu, et al.
Published: (2019-08-01)